SCHEMBL2443347

SCHEMBL2443347

COCCN1CCC([NH])CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.41
HSD11B1 P28845 1/20 0.39
ALDH1A1 P00352 1/20 0.37
GBA1 P04062 2/20 0.37
NPC1 O15118 1/20 0.36
HRH1 P35367 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PARP1 P09874 1/20 0.34
ACKR3 P25106 1/20 0.33
DRD2 P14416 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CDK1 P06493 1/20 0.33
CDK4 P11802 1/20 0.33
CCNA2 P20248 1/20 0.33
CCNE1 P24864 1/20 0.33
CDK2 P24941 1/20 0.33
CCND3 P30281 1/20 0.33
CDK6 Q00534 1/20 0.33
MAPK11 Q15759 1/20 0.33
MAPK14 Q16539 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1570155 0.80 HSD11B1 (0.44) KDM1AHSD11B1ALDH1A1GBA1NPC1
SCHEMBL12607 0.80 ALDH1A1 (0.53) ALDH1A1SIGMAR1KDM4EKMT2ATDP1
SCHEMBL18776398 0.80 KDM1A (0.42) KDM1AHSD11B1ALDH1A1GBA1NPC1
SCHEMBL26031963 0.80 KDM1A (0.42) KDM1AHSD11B1ALDH1A1GBA1NPC1
SCHEMBL259415 0.78 GBA1 (0.44) KDM1AHSD11B1ALDH1A1GBA1NPC1
SCHEMBL633682 0.78 KDM1A (0.41) KDM1AHSD11B1ALDH1A1GBA1NPC1
SCHEMBL14488177 0.78 KDM1A (0.41) KDM1AHSD11B1ALDH1A1GBA1NPC1
SCHEMBL4761260 0.78 KDM1A (0.41) KDM1AHSD11B1ALDH1A1GBA1NPC1
SCHEMBL18664097 0.78 KDM1A (0.41) KDM1AHSD11B1ALDH1A1GBA1NPC1
SCHEMBL19983442 0.78 KDM1A (0.41) KDM1AHSD11B1ALDH1A1GBA1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2215085-B1 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2011-09-07 EP disclosed